263 related articles for article (PubMed ID: 8270878)
1. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
Cromme FV; Airey J; Heemels MT; Ploegh HL; Keating PJ; Stern PL; Meijer CJ; Walboomers JM
J Exp Med; 1994 Jan; 179(1):335-40. PubMed ID: 8270878
[TBL] [Abstract][Full Text] [Related]
2. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
[TBL] [Abstract][Full Text] [Related]
3. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
[TBL] [Abstract][Full Text] [Related]
4. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of the peptide transporters in escape variants of human renal cell carcinomas.
Seliger B; Höhne A; Jung D; Kallfelz M; Knuth A; Jaeger E; Bernhard H; Momburg F; Tampé R; Huber C
Exp Hematol; 1997 Jul; 25(7):608-14. PubMed ID: 9216736
[TBL] [Abstract][Full Text] [Related]
6. Peptide selection by MHC-encoded TAP transporters.
Momburg F; Neefjes JJ; Hämmerling GJ
Curr Opin Immunol; 1994 Feb; 6(1):32-7. PubMed ID: 8172678
[TBL] [Abstract][Full Text] [Related]
7. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
[TBL] [Abstract][Full Text] [Related]
8. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.
Lewis JW; Neisig A; Neefjes J; Elliott T
Curr Biol; 1996 Jul; 6(7):873-83. PubMed ID: 8805302
[TBL] [Abstract][Full Text] [Related]
9. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.
Keating PJ; Cromme FV; Duggan-Keen M; Snijders PJ; Walboomers JM; Hunter RD; Dyer PA; Stern PL
Br J Cancer; 1995 Aug; 72(2):405-11. PubMed ID: 7640226
[TBL] [Abstract][Full Text] [Related]
10. HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern.
Wainwright SD; Biro PA; Holmes CH
J Immunol; 2000 Jan; 164(1):319-28. PubMed ID: 10605026
[TBL] [Abstract][Full Text] [Related]
11. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
[TBL] [Abstract][Full Text] [Related]
12. Dependence of peptide binding by MHC class I molecules on their interaction with TAP.
Grandea AG; Androlewicz MJ; Athwal RS; Geraghty DE; Spies T
Science; 1995 Oct; 270(5233):105-8. PubMed ID: 7569935
[TBL] [Abstract][Full Text] [Related]
13. Expression of HLA class I antigens in transporter associated with antigen processing (TAP)-deficient mutant cell lines.
Young NT; Mulder A; Cerundolo V; Claas FH; Welsh KI
Tissue Antigens; 1998 Oct; 52(4):368-73. PubMed ID: 9820600
[TBL] [Abstract][Full Text] [Related]
14. Function of the transport complex TAP in cellular immune recognition.
Abele R; Tampé R
Biochim Biophys Acta; 1999 Dec; 1461(2):405-19. PubMed ID: 10581370
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
[TBL] [Abstract][Full Text] [Related]
16. HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP.
Lee N; Geraghty DE
J Immunol; 2003 Nov; 171(10):5264-71. PubMed ID: 14607927
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.
Jun Y; Kim E; Jin M; Sung HC; Han H; Geraghty DE; Ahn K
J Immunol; 2000 Jan; 164(2):805-11. PubMed ID: 10623826
[TBL] [Abstract][Full Text] [Related]
18. Interaction of MHC class I molecules with the transporter associated with antigen processing.
Suh WK; Cohen-Doyle MF; Fruh K; Wang K; Peterson PA; Williams DB
Science; 1994 May; 264(5163):1322-6. PubMed ID: 8191286
[TBL] [Abstract][Full Text] [Related]
19. A rare transporter associated with antigen processing polymorphism overpresented in HLAlow colon cancer reveals the functional significance of the signature domain in antigen processing.
Yang T; Lapinski PE; Zhao H; Zhou Q; Zhang H; Raghavan M; Liu Y; Zheng P
Clin Cancer Res; 2005 May; 11(10):3614-23. PubMed ID: 15897556
[TBL] [Abstract][Full Text] [Related]
20. Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter.
Yewdell JW; Esquivel F; Arnold D; Spies T; Eisenlohr LC; Bennink JR
J Exp Med; 1993 Jun; 177(6):1785-90. PubMed ID: 8496691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
